ProHealth BPC-157 is sold as a research peptide, not an FDA-approved drug. Here is what US buyers should know about forms, dosing charts, and safety.
ProHealth BPC-157 is a peptide product sold by ProHealth, a US-based supplement retailer, most often under the brand name BPC-157 BioMax. It is marketed as a research or dietary supplement rather than a prescription drug, and BPC-157 is not FDA-approved for human use in the United States. Anyone buying it is buying an unapproved substance whose safety and effectiveness have not been established in large human trials.
What Is ProHealth BPC-157 and What Is In It?
BPC-157 is a synthetic peptide made of 15 amino acids. Its nickname, body protection compound, comes from a fragment of a protein found naturally in human gastric juice. If you have ever wondered what is bpc-157 made of, the answer is straightforward: it is a lab-synthesized chain of amino acids, not a plant extract or a vitamin.
ProHealth sells its version under the BioMax label and describes it as a research-grade peptide. Product pages list the amount per serving along with storage instructions. That labeling does not change the regulatory picture, because the FDA has not approved BPC-157 for any human medical use.
The BioMax name is ProHealth's own branding, so bpc-157 biomax and ProHealth BPC-157 refer to the same product line. Other vendors sell the same peptide as vials, capsules, or topical creams.
Common Forms and How They Compare
| Form | Typical listed amount | How it is marketed | Main caveat |
|---|---|---|---|
| Capsules (BioMax and similar) | 250 to 500 mcg per capsule | Oral gut and recovery support | Peptides are likely broken down in the stomach; little human data |
| Lyophilized vial | 5 mg or 10 mg per vial | Research use only | Requires reconstitution; sterility and dosing errors are real risks |
| Sublingual drops | 200 to 500 mcg per dose | Fast absorption claims | Absorption claims are not supported by published human trials |
| Topical cream or serum | Varies widely | Localized skin or joint area | Little to no human evidence |
Price, purity, and packaging vary a lot between sellers, so comparing two products by milligram count alone tells you very little. Two vials both labeled 5 mg can differ substantially in actual peptide content. A published independent lab report is the only practical way to check that claim.
What the Research Shows, and What It Does Not
Most published BPC-157 research has been done in animals, mainly rats and mice. Those studies looked at tendon and ligament healing, stomach ulcers, and gut inflammation. Rodent results are interesting, but they do not automatically transfer to people.
Human data is thin. There are small studies and scattered case reports, but no large randomized controlled trial in healthy adults that establishes a standard dose or a long-term safety profile. Anyone who claims otherwise is going beyond what the evidence supports.
BPC-157 shows promising results in animal models, but there is no large human trial confirming its safety or effectiveness.
Dosing: Why There Is No Standard Chart
Many people search for a bpc-157 dosage chart by weight, but no such chart is backed by human clinical trials. Weight-based dosing exists for FDA-approved drugs because those drugs went through trials that measured blood levels and outcomes. BPC-157 has not.
Forum protocols often land somewhere between 250 mcg and 500 mcg per day, split into one or two doses. Those numbers come from user reports rather than controlled studies, so treat them as anecdotes instead of standards.
Athletes comparing a bpc-157 and tb-500 dosage for injury should know that both peptides are banned by WADA and neither is approved by the FDA. Stacking two unapproved substances does not make either one safer or better studied.
Injecting an unapproved peptide also adds risks that oral use does not, including contamination, incorrect reconstitution, and infection at the injection site. Using sterile technique reduces some of that risk, but it does not remove it.
Safety, Legality, and Reported Side Effects
BPC-157 is not FDA-approved, and in 2023 the FDA placed it on the list of bulk drug substances that may not be used in compounded medications. That decision cited limited safety data and questions about immune reactions and effects on blood vessel formation.
Reported bpc-157 negative effects in user forums include injection-site pain, nausea, dizziness, and headaches. Because those reports are anecdotal, the true frequency of side effects is unknown, and long-term effects in humans have not been studied.
If you take prescription medication, are pregnant or nursing, or manage a chronic condition, talk with a healthcare professional before experimenting with any peptide. This article is general information and not medical advice.
How to Evaluate ProHealth and Other Sellers
Reading prohealth bpc-157 reviews can help you gauge shipping speed and customer service, but reviews rarely prove purity. Look for these items instead:
- A certificate of analysis (COA) from an independent lab, matched to the lot number on your vial or bottle
- Clear labeling of the exact peptide amount per serving
- A stated return or refund policy
- Honest research-only language rather than disease-treatment claims
Vendors that promise to cure injuries or replace medical treatment are a red flag. Reputable sellers of unapproved peptides usually keep research-use-only disclaimers front and center.
Bottom Line
ProHealth BPC-157 is one brand's version of an unapproved peptide, sold as a research or dietary supplement rather than a medicine. Animal studies suggest possible benefits for tissue healing and gut inflammation, but human evidence is limited and no standard dose exists.
Buying from a vendor with published third-party testing lowers some quality risk, but it does not make the product FDA-approved or clinically proven. If you are considering BPC-157 for a health issue, discuss it with a licensed healthcare professional first.
RELATED PEPTIDE TOPICBPC-157 peptideFrequently Asked Questions
Is ProHealth BPC-157 FDA-approved?
No. BPC-157 is not FDA-approved for human use in the United States, and in 2023 the FDA placed it on the list of bulk substances that cannot be used in compounded medications. ProHealth sells it as a research or dietary supplement, which is a different regulatory category than a prescription drug.
What is the difference between BPC-157 and BPC-157 BioMax?
BPC-157 is the name of the peptide itself, a synthetic chain of 15 amino acids. BioMax is ProHealth's branded product line for that same peptide, so the two names describe the same ingredient sold by the same company. Other brands use their own labels for the identical molecule.
Does BPC-157 have side effects?
User forums report injection-site pain, nausea, dizziness, and headaches, but these accounts are anecdotal, so the real frequency is unknown. Long-term safety, including any effect on cancer risk, has not been studied in humans. Anyone with a chronic condition or taking prescription medication should consult a healthcare professional before using it.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.